首页 >
法规速递
-
Page: Acenocoumarol product-specific bioequivalence guidance-2025/6/30
2025-07-01查看详情 > -
Page: Voriconazole product-specific bioequivalence guidance-2025/6/30
2025-07-01查看详情 > -
Page: Periodic safety update reports (PSURs)-2025/6/30
2025-07-01查看详情 > -
Page: Tadalafil product-specific bioequivalence guidance-2025/6/30
2025-07-01查看详情 > -
Page: Repaglinide product-specific bioequivalence guidance-2025/6/30
2025-07-01查看详情 > -
Document: Process for submitting existing data on medicinal products authorised for human use – SIAMED II & XEVMPD to PMS deltas - Chapter 9-2025/6/30
2025-07-01查看详情 > -
Page: PRAC recommendations on safety signals-2025/6/30
2025-07-01查看详情 > -
Document: List of signals discussed at PRAC since September 2012-2025/6/30
2025-07-01查看详情 > -
Document: PRAC recommendations on signals adopted at the 2-5 June 2025 PRAC meeting-2025/6/30
2025-07-01查看详情 > -
Page: Requesting scientific advice or protocol assistance from EMA-2025/6/30
2025-07-01查看详情 >
